Acasti PharmaCompany Review & Valuation
ACST
TSX Venture Exchange
Latest Price
0.80CAD
Market Capitalization
72.17mCAD
About Acasti Pharma Inc.
Acasti Pharma Inc., a biopharmaceutical company, focuses on the research, development, and commercialization of prescription drugs for the treatment of cardiovascular diseases. Its lead product candidate is CaPre, an omega-3 phospholipid therapeutic that is in Phase III clinical trial to treat patie… Show more nts with hypertriglyceridemia. The company was incorporated in 2002 and is headquartered in Laval, Canada. Show less
Stock Price
Price data not available for Acasti Pharma.
Performance
Please login or create a free account to view the contents of this section.
Valuation
Please login or create a free account to view the contents of this section.